Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcriptomic response to ex vivo IL33 stimulation of blood eosinophils from mepolizumab- or omalizumab-treated patients


ABSTRACT: Coding RNA expression of blood eosinophils from mepolizumab- or omalizumab-treated patients stimulated ex vivo with IL-33 for 6 hours and of directly processed non-stimulated blood eosinophils from the same samples (paired design)

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Christophe Desmet 

PROVIDER: E-MTAB-10189 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma.

Van Hulst Glenn G   Jorssen Joseph J   Jacobs Nathalie N   Henket Monique M   Louis Renaud R   Schleich Florence F   Bureau Fabrice F   Desmet Christophe J CJ  

The European respiratory journal 20220317 3


Neutralising antibodies against the cytokine interleukin (IL)5 have become widely used for the control of severe eosinophilic asthma. Remarkably, patients receiving neutralising anti-IL5 biological therapies retain a very stable population of residual blood eosinophils. Whether these residual eosinophils are endowed with particular biological activity has not yet been studied, but is of importance in predicting potential long-term effects of IL5 neutralisation in patients. To tackle the effect o  ...[more]

Similar Datasets

2021-12-17 | E-MTAB-10190 | biostudies-arrayexpress
2021-12-17 | E-MTAB-10188 | biostudies-arrayexpress
2007-10-27 | E-GEOD-3982 | biostudies-arrayexpress
2024-11-19 | E-MTAB-13710 | biostudies-arrayexpress
2023-07-01 | E-MTAB-11028 | biostudies-arrayexpress
2020-02-21 | E-MTAB-8581 | biostudies-arrayexpress
2014-08-25 | E-GEOD-53513 | biostudies-arrayexpress
2022-12-16 | E-MTAB-12437 | biostudies-arrayexpress
2013-06-06 | E-GEOD-47636 | biostudies-arrayexpress
2018-03-18 | E-MTAB-6301 | biostudies-arrayexpress